HB 1617 Florida House · 2025 Regular Session

Stem Cell Therapy

Summary
Stem Cell Therapy ; Authorizes allopathic physicians & osteopathic physicians to perform stem cell therapy not approved by United States Food & Drug Administration; specifies requirements for stem cells that may be used by allopathic physicians & osteopathic physicians; requires allopathic physicians & osteopathic physicians to adhere to applicable current good manufacturing practices in performance of such therapies; prohibits allopathic physicians & osteopathic physicians from obtaining stem cells for therapies from facilities failing to meet certain requirements; requires allopathic physicians & osteopathic physicians to include certain terms in contracts or agreements with facilities producing stem cells for therapies; requires allopathic physicians & osteopathic physicians to include specified notice in any form of advertisement; provides requirements for such notice; requires allopathic physicians & osteopathic physicians to obtain signed consent form from patient or his or her representative before performing therapy; specifies requirements for consent form; requires Board of Medicine & Board of Osteopathic Medicine to adopt rules, respectively.
Bill status in committee 3 of 5 stages cleared
Introduction
Feb 2025
Committee Review
Apr 2025
House Passage
Apr 2025
Senate Passage
Governor
Introduced Feb 28, 2025 Last action Apr 30, 2025
Maddy AI version diff · 2 comparisons

What changed between versions

H 1617 c1 H 1617 c2 · 7 edits
MODERATE
This bill was significantly rewritten to expand its scope and clarify its requirements. The original version applied to all healthcare providers, while the new version specifically targets allopathic and osteopathic physicians. The bill now creates two new Florida statutes instead of one, and the definition of covered stem cell products was narrowed to focus primarily on umbilical cord and cord blood sources.
Scope change
The bill's applicability changed from all healthcare providers to specifically allopathic and osteopathic physicians only.
ELIGIBILITY

Changed from applying to all healthcare providers to specifically targeting allopathic physicians and osteopathic physicians.

DEFINITION

Narrowed the definition of covered stem cell products to focus on umbilical cord and cord blood sources obtained from US residents.

Removed specific examples of excluded products like skin, dura mater, heart valves, corneas, and peripheral venous circulation from the definition.

Added new exclusions for computer products created using human cells and tissues.

REQUIREMENT

Added new requirements prohibiting physicians from obtaining stem cells from facilities that fail to meet certain standards.

Added new contract requirements between physicians and facilities producing stem cells for therapies.

ENFORCEMENT

Changed rule-making authority from the Department of Health to the Board of Medicine and Board of Osteopathic Medicine.

Floor votes · House Apr 22, 2025

How they voted

220
Passed · 5 other
Total votes 27
Apr 22, 2025
D Democratic8
5 Yea 3
62% Yea
R Republican19
17 Yea 2
89% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
23
Key actions
9
Committee
12
Apr 24, 2025
Committee
Bill referred to House Calendar
lower
Apr 22, 2025
House · Passed
House Vote: pass (22-0-5)
house
Apr 22, 2025
Lower · Passed
Reported out of Health & Human Services Committee
lower
Apr 22, 2025
Lower · Passed
Favorable with CS by Health & Human Services Committee
lower
Apr 21, 2025
Lower · Passed
Added to Health & Human Services Committee agenda
lower
Apr 4, 2025
Lower · Passed
Now in Health & Human Services Committee
lower
Apr 4, 2025
Committee
Referred to Health & Human Services Committee
lower
Apr 3, 2025
Lower · Passed
Reported out of Health Professions & Programs Subcommittee
lower
Apr 3, 2025
Lower · Passed
Favorable with CS by Health Professions & Programs Subcommittee
lower
Apr 1, 2025
Lower · Passed
Added to Health Professions & Programs Subcommittee agenda
lower
Mar 5, 2025
Lower · Passed
Now in Health Professions & Programs Subcommittee
lower
Mar 5, 2025
Committee
Referred to Health & Human Services Committee
lower
Mar 5, 2025
Committee
Referred to Health Professions & Programs Subcommittee
lower
1 primary · 1 co-sponsor

Sponsors